west virginia glp-1 vomiting lawsuit A class-action has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly's blockbuster drug to treat obesity. When the major pharmacy benefit manager informed patients ATLANTA - A Georgia woman

Loose skin poses a real concern if you are experiencing rapid weight loss with GLP-1 drugs: sagging skin can be uncomfortable, affect how clothing fits, cause skin irritation, and even pose a hygiene problem

To protect muscle during treatment: Encourage strength training and physical activity Ensure adequate protein intake Use tools to monitor body composition, not just weight This helps patients maintain functionality while still achieving the metabolic benefits of treatment

Observational studies indicate a potential reduced risk of developing dementia, including Alzheimers, in patients using GLP-1 agonists [16, 23]

non-oral contraception or additional barrier methods are recommended for 4 weeks after initiation and dose increases

Waser, B